[ad_1] Pfizer PFE-N said on Wednesday that Canada’s health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B. Canada’s approval comes ahead…
Tag: Gene
Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma
[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. …
Exploring the limitations of artificial intelligence for businesses — Gene Marks
[ad_1] While artificial intelligence is taking the world by storm, many have expressed anxieties over the technology’s rapid acceptance by the business community. Even though the benefits of platforms such…
Wonka (2023): Is the Movie a Prequel to Gene Wilder’s Willy Wonka and the Chocolate Factory?
[ad_1] Timothée Chalamet’s Wonka is all set to hit US theaters and much of the world this Friday, but fans have long been curious about whether or not the latest…
Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus
[ad_1] In the peer reviewed publication, the International Journal of Plant Biology, Cibus provides two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus (canola, winter…
German researchers welcome national, EU support for gene therapy research
[ad_1] National and EU-level support goes a long way towards supporting research into gene therapies against rare diseases, according to German researchers, but Europe still lags behind North American countries…
BioMarin prices hemophilia gene therapy at nearly 29,000 euros per vial in Germany
[ad_1] Nov 28 (Reuters) – BioMarin Pharmaceutical (BMRN.O) said on Tuesday it will price its therapy for severe hemophilia A at 28,933.53 euros ($31,725.62) per vial for insurers covering a…
Gene Editing Will Change Medicine—and Maybe Health Investing Too
[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…
Genentech Veteran Named New BioMarin CEO as Gene Therapy Launch Ramps Up – MedCity News
[ad_1] Jean-Jacques Bienaimé, who over the course of nearly two decades grew BioMarin Pharmaceutical’s portfolio from a single commercialized asset to multiple marketed products—including a landmark approval in gene therapy—is…
FDA moves closer to sickle cell cure that uses gene editing
[ad_1] The Food and Drug Administration may be one step closer toward what could be the first approval of a drug that uses the groundbreaking gene-editing tool CRISPR. The drug,…